Why Sagility India Shares Slipped Despite 46% Q1 Profit Jump; Nomura Retains Buy, Cuts Target Price

Sagility India shares slipped over 1% on July 22 despite the company reporting a strong set of Q1 FY27 results, with robust growth in both revenue and profitability. Investors remained cautious after management highlighted margin pressures, while brokerage Nomura marginally reduced its target price despite reaffirming a Buy rating.

The healthcare-focused business process management (BPM) company delivered healthy operational performance during the June quarter, driven by new client additions, higher deal wins, and continued expansion across existing customers. However, forex losses, wage-related costs, and a slight contraction in margins weighed on investor sentiment.

Sagility India Share Price Performance

Following the quarterly earnings announcement, Sagility India shares traded lower on the NSE.

Stock Performance

Metric	Performance
Share Price	₹41.32
Intraday Change	-1.24%
NSE Trading Time	Around 1:52 PM

Sagility India Q1 FY27 Financial Results

For the quarter ended June 30, 2026, Sagility India reported a 46% year-on-year increase in consolidated net profit to ₹217 crore, compared to ₹149 crore in the corresponding quarter last year.

Revenue from operations increased 27.6% to ₹1,963 crore, while EBITDA rose 26.6% to ₹438 crore. EBITDA margin, however, declined slightly to 22.3% from 23.0% a year earlier.

Q1 FY27 Financial Performance

Metric	Q1 FY27	Q1 FY26	YoY Change
Revenue from Operations	₹1,963 crore	₹1,539 crore	+27.6%
Net Profit	₹217 crore	₹149 crore	+46.0%
EBITDA	₹438 crore	₹346 crore	+26.6%
EBITDA Margin	22.3%	23.0%	Slightly Lower

Operational Highlights

Sagility continued to strengthen its client portfolio during the quarter by adding 27 new clients, including CareSeed, taking its total client base to 109.

The company also recorded USD 35.3 million in Annual Contract Value (ACV) during the quarter, driven by expansion across existing customers and one new client win.

Business Highlights

Particular	Details
Total Clients	109
New Clients Added	27
Key New Client	CareSeed
New ACV Won	USD 35.3 million

Nomura Retains Buy Rating

Following the results, Nomura retained its Buy rating on Sagility India but marginally reduced its target price.

The brokerage lowered its target price to ₹52 from ₹53, primarily due to higher forex losses and the impact of statutory minimum wage increases.

Latest Brokerage View

Brokerage	Rating	Target Price	Previous Target
Nomura	Buy	₹52	₹53

Key Takeaways from Nomura

Nomura noted that:

• Revenue reached USD 207.8 million, slightly ahead of estimates.
• Constant currency revenue grew 15% YoY and around 5% QoQ after adjusting for seasonal factors.
• EBITDA margin of 23.8% came broadly in line with expectations.
• Reported profit was impacted by forex losses and higher minimum wage provisions.
• Diluted EPS increased 44% year-on-year.

The brokerage expects the company to deliver low double-digit organic constant currency revenue growth during FY27 while maintaining an EBITDA margin of 24–25%.

Acquisition Strategy Strengthens Growth

Nomura highlighted that recent acquisitions continue to strengthen Sagility's healthcare capabilities.

The acquisition of BroadPath has enhanced seasonal and member-facing healthcare operations, while CareSeed expands the company's healthcare quality analytics capabilities, particularly for Medicare Advantage plans and the mid-market segment.

AI to Improve Productivity

Management expects artificial intelligence to improve operational efficiency over the long term.

While AI could result in approximately 2% revenue compression during FY27, the impact has already been factored into the company's financial guidance.

Why Did Sagility Shares Fall?

Despite reporting strong earnings, the stock traded lower because investors focused on:

• Slight decline in EBITDA margin.
• Higher forex losses.
• Increased employee costs due to statutory wage revisions.
• Marginal reduction in Nomura's target price.

Key Positives

• Net profit increased 46% year-on-year.
• Revenue grew 27.6%.
• Added 27 new clients during the quarter.
• Strong ACV wins of USD 35.3 million.
• Nomura maintained its Buy rating.

Key Risks

• Margin pressure from wage inflation.
• Forex volatility impacting earnings.
• AI-led efficiency gains could temporarily reduce revenue.
• Higher employee costs may weigh on profitability.

Why did Sagility India shares fall after Q1 results?

The stock declined despite strong earnings as investors remained cautious over margin compression, forex losses, and higher employee costs.

What was Sagility India's Q1 FY27 net profit?

The company reported a consolidated net profit of ₹217 crore, up 46% year-on-year.

How much did Sagility India's revenue grow?

Revenue from operations increased 27.6% to ₹1,963 crore during Q1 FY27.

What is Nomura's target price for Sagility India?

Nomura maintained its Buy rating while reducing its target price slightly to ₹52 from ₹53.

How many clients did Sagility add during Q1 FY27?

Sagility added 27 new clients, taking its total client base to 109.